NPI: 1962764563 · TOPEKA, KS 66606 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 06/11/2012
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 06/11/2012 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 15,330 | $320K |
| 2019 | 14,101 | $375K |
| 2020 | 16,778 | $391K |
| 2021 | 14,324 | $164K |
| 2022 | 8,885 | $150K |
| 2023 | 10,573 | $367K |
| 2024 | 4,400 | $256K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 21,553 | 2,039 | $1.83M |
| 90935 | Hemodialysis procedure with single evaluation by a physician | 3,088 | 245 | $172K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 23,219 | 1,674 | $14K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 213 | 122 | $3K |
| J1270 | Injection, doxercalciferol, 1 mcg | 10,654 | 1,106 | $2K |
| J1756 | Injection, iron sucrose, 1 mg | 5,989 | 1,702 | $2K |
| 90677 | 18 | 18 | $1K | |
| A4657 | Syringe, with or without needle, each | 6,251 | 2,206 | $440.32 |
| A9270 | Non-covered item or service | 2,566 | 309 | $299.52 |
| 90674 | 59 | 53 | $148.85 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 706 | 399 | $146.34 |
| 91320 | 14 | 14 | $131.10 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 853 | 647 | $105.48 |
| 83970 | 1,639 | 1,403 | $87.16 | |
| 90480 | 14 | 14 | $40.74 | |
| 82728 | 901 | 757 | $27.49 | |
| 83550 | 805 | 669 | $16.10 | |
| 85045 | 1,512 | 1,317 | $8.56 | |
| 83540 | 933 | 783 | $7.68 | |
| 85041 | 1,617 | 1,402 | $2.82 | |
| 85048 | 1,605 | 1,393 | $2.61 | |
| G0009 | Administration of pneumococcal vaccine | 19 | 19 | $0.01 |
| G0008 | Administration of influenza virus vaccine | 61 | 54 | $0.00 |
| 82108 | 102 | 84 | $0.00 |